The upcoming report from RH (RH) is expected to reveal quarterly loss of $0.09 per share, indicating an increase of 77.5% compared to the year-ago period. Analysts forecast revenues of $818.24 million, representing an increase of 12.6% year over year.The consensus EPS estimate for the quarter has been revised 0.1% higher over the last 30 days to the current level. This reflects how the analysts covering the stock have collectively reevaluated their initial estimates during this timeframe.Prior to a company' ...

Have you been paying attention to shares of Crown Holdings (CCK) ? Shares have been on the move with the stock up 2.9% over the past month. The stock hit a new 52-week high of $101 in the previous session. Crown Holdings has gained 21.7% since the start of the year compared to the -0.4% move for the Zacks Industrial Products sector and the 6.9% return for the Zacks Containers - Metal and Glass industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it ...

Did you analyze how Ciena (CIEN) fared in its international operations for the quarter ending April 2025? Given the widespread global presence of this developer of high-speed networking technology, scrutinizing the trends in international revenues becomes imperative to assess its financial strength and future growth possibilities.In today's increasingly interconnected global economy, a company's ability to tap into international markets can be a pivotal factor in shaping its overall financial health and gro ...

Have you been paying attention to shares of Catalyst Pharmaceutical (CPRX) ? Shares have been on the move with the stock up 8.4% over the past month. The stock hit a new 52-week high of $26.58 in the previous session. Catalyst Pharmaceutical has gained 23.8% since the start of the year compared to the -3.5% move for the Zacks Medical sector and the 4% return for the Zacks Medical - Drugs industry.What's Driving the Outperformance?The stock has an impressive record of positive earnings surprises, as it hasn' ...

CoreWeave (NASDAQ: CRWV) shares plunged Tuesday after a critical analyst note from D.A. Davidson raised concerns about the cloud computing company’s financial fundamentals and outlook.As of press time, CoreWeave’s stock was trading at $150.49, down 7% on the day. The selloff is particularly notable given that shares had rallied approximately 160% over the past month.CRWV one-day stock price chart. Source: Google Finance That impressive run-up has been fueled mainly by ongoing enthusiasm around artificial in ...

Fourth-generation Master Distiller Graciela Gonzalez brings an old family recipe back to life with Cortada™ Blanco and Reposado Smoked Tequila, debuting in Denver this summerST. LOUIS, June 10, 2025 /PRNewswire/ -- Luxco, Inc. announces the launch of Cortada Smoked Tequila – a new premium tequila cut with a whisper of smoke. Offering both Blanco and Reposado varieties, Cortada Smoked Tequila is available exclusively in Denver and through e-commerce in partnership with Shared Pour. Cortada Smoked Tequila Bla ...

Eli Lilly and Company (NYSE:LLY) Goldman Sachs 46th Annual Global Healthcare Conference June 10, 2025 8:00 AM ET Company Participants Lucas E. Montarce - Executive VP & CFO Michael Czapar - Director of Investor Relations Conference Call Participants Unidentified Analyst Get started here. Welcome to day 2 of our healthcare conference. The weather is still holding up. Thank God for that. Very pleased to kick off our morning session this morning with Eli Lilly. We have Lucas Montarce, CFO; and Mike Czapar, Sen ...

Key Takeaways IBM Software revenue rose to $6.34B in Q1 2025 from $5.9B, led by cloud and AI-focused offerings. HashiCorp buyout boosts IBM's Red Hat, watsonx and automation tools for hybrid cloud and IT security. Segment revenue is projected to grow 11.6% YoY to $7.52B in 2025, driven by hybrid cloud and automation.International Business Machines Corporation’s (IBM) Software segment is increasingly gaining traction with an increasing demand for a focused portfolio that provides end-to-end hybrid cloud an ...

Key Takeaways ALNY secured EC approval to expand Amvuttra's use to treat ATTR-CM in adult patients. Approval was based on HELIOS-B data showing mortality, CV event and symptom improvement. Amvuttra is now the first RNAi therapy approved in the EU for both ATTR-CM and hATTR-PN.Alnylam Pharmaceuticals, Inc. (ALNY) announced that the European Commission (EC) has approved a label expansion of its RNAi therapeutic Amvuttra.The EC has now approved Amvuttra for the treatment of wild-type or hereditary transthyre ...

Alexandr Wang, CEO of Scale AI, arrives for a meeting with international investors in IA at the Elysee Palace as part of the Artificial Intelligence (AI) Action Summit in Paris, France, Feb. 10, 2025.Meta is forming a new artificial intelligence research lab and bringing on Alexandr Wang, the founder and CEO of the startup Scale AI, according to The New York Times.The research lab is going to pursue a concept known as "superintelligence," which is an AI system that surpasses human intelligence, The New York ...